Thryvv : ratio page

Titan Bio-Tech

Overview Articles Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2024
Mar2023
Mar2022
Mar2021
Mar2020
Valuation Parameters:
PE(x)
17.56
6.55
9.99
5.05
4.99
PCE(x)
16.17
6.89
9.00
4.52
3.66
Price/Book(x)
3.27
1.48
2.51
2.23
0.90
Yield(%)
0.38
0.91
0.57
0.81
2.34
EV/Net Sales(x)
2.69
1.14
1.76
1.14
0.72
EV/Core EBITDA(x)
12.23
5.24
6.75
3.45
4.11
EV/EBIT(x)
13.48
5.71
7.28
3.65
4.49
EV/CE(x)
3.13
1.41
2.32
1.46
0.73
MCap / Sales
2.66
1.13
1.75
1.08
0.44
Growth Ratio:
Net Sales Growth(%)
13.94
16.55
-13.14
79.05
22.39
Core EBITDA Growth(%)
14.52
-2.32
-31.43
237.04
45.31
EBIT Growth(%)
13.29
-3.28
-32.84
248.46
61.82
PAT Growth(%)
12.55
-3.04
-31.61
304.54
100.33
EPS Growth(%)
0.04
14.57
-28.52
329.32
100.60
Financial Stability Ratios:
Total Debt/Equity(x)
0.05
0.06
0.09
0.21
0.61
Current Ratio(x)
2.97
2.74
2.95
2.33
2.06
Quick Ratio(x)
1.28
1.43
1.51
1.24
0.81
Interest Cover(x)
27.95
38.69
34.22
25.72
5.43
Total Debt/Mcap(x)
0.02
0.04
0.03
0.09
0.68
Operational & Financial Ratios:
Earnings Per Share (Rs)
30.07
30.06
26.24
36.71
8.55
CEPS(Rs)
32.67
28.59
29.11
41.05
11.66
DPS(Rs)
2.00
1.80
1.50
1.50
1.00
Book NAV/Share(Rs)
161.49
133.00
104.36
83.21
47.42
Tax Rate(%)
24.95
25.22
25.15
25.76
24.67
Margin Ratios:
Core EBITDA Margin(%)
20.89
20.50
25.31
32.47
16.98
EBIT Margin(%)
19.93
20.04
24.15
31.24
16.05
Pre Tax Margin(%)
19.22
19.53
23.45
30.02
13.10
PAT Margin (%)
14.42
14.60
17.55
22.29
9.87
Cash Profit Margin (%)
16.45
16.41
19.47
23.85
12.13
Performance Ratios:
ROA(%)
15.46
16.37
19.16
33.50
10.89
ROE(%)
19.45
21.44
27.98
58.74
21.97
ROCE(%)
25.39
27.40
33.74
60.80
21.45
Asset Turnover(x)
1.07
1.12
1.09
1.50
1.10
Sales/Fixed Asset(x)
2.65
2.84
2.62
3.29
2.04
Working Capital/Sales(x)
3.09
3.00
2.64
3.60
3.34
Efficiency Ratios:
Fixed Capital/Sales(x)
0.38
0.35
0.38
0.30
0.49
Receivable days
44.12
47.36
50.91
38.45
48.49
Inventory Days
90.92
89.79
99.29
77.64
112.82
Payable days
21.53
25.39
24.97
23.89
29.07